Vitamin D as an Immunomodulator: Risks with Deficiencies and Benefits of Supplementation.

Healthcare (Basel) · 2015 · PMC4939543 · PMID 27417758

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

failed to reach statistical significanceP = 0.06so close (0.05 < p ≤ 0.1)

In a 103-patient double-blind RCT, vitamin D administration reduced relapse rates in CD by greater than 2-fold but failed to reach statistical significance ( P = 0.06), thought to be due to insufficient power of the study [ 51 ].

also in 6,035 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.